Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Administrative updates: v3.4.2 was added; a government funding lapse notice (and the v3.4.1 revision notice) was removed. These changes do not affect study content or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:13:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center status, with links to cc.nih.gov and opm.gov. Updated the page revision tag from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:22:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary display added; QC-related metadata including 'Last Update Submitted that Met QC Criteria' and the revision 'v3.4.0' were introduced, while older QC wording and the previous revision 'v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:20:46.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision history shows an addition of v3.3.4 and removal of v3.3.3; no study data, eligibility criteria, or locations are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:05:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2; these are minor footer/site updates that do not alter trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:36:56.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    New revision identifier v3.3.2 is shown, replacing the previous v3.2.0. This change does not affect study data, eligibility criteria, endpoints, or trial status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:39:32.000Z thumbnail image

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.